jagomart
digital resources
picture1_Csr Ppt Templates 71777 | Recording And Reporting Clinical Trial Results


 172x       Filetype PPTX       File size 0.37 MB       Source: toolbox.eupati.eu


File: Csr Ppt Templates 71777 | Recording And Reporting Clinical Trial Results
clinical study report csr european patients academy on therapeutic innovation the trial sponsor compiles a detailed clinical study report csr after each clinical trial this report follows a format laid ...

icon picture PPTX Filetype Power Point PPTX | Posted on 31 Aug 2022 | 3 years ago
Partial capture of text on file.
     Clinical Study Report (CSR)
                                                                     European Patients’ Academy 
                                                                      on Therapeutic Innovation
      The trial sponsor compiles a detailed clinical study report 
         (CSR) after each clinical trial. 
      This report follows a format laid down by the regulatory 
         authorities.
      The CSR can be hundreds of pages long.
      Access to the complete CSR is usually limited to the 
         sponsor and the regulatory authorities that are assessing 
         the marketing authorisation application (MAA).
                                                                                2
     Public access to information from 
     the CSR                                                         European Patients’ Academy 
                                                                      on Therapeutic Innovation
     Information summarised from the CSR can be shared with  
     the public through:
      European Public Assessment Reports (EPARs),
      Clinical trial registries,
      Marketing authorisation product information,
      Journal papers,
      Conferences,
      Patient organisation websites, and
      Popular news media.
                                                                                3
     European Public Assessment 
     Reports (EPAR)                                                  European Patients’ Academy 
                                                                      on Therapeutic Innovation
      When authorisation for a new medicine is sought via the 
         Centralised Procedure (CP), an assessment report, an 
         EPAR, is written by the European Medicines Agency 
         (EMA). 
      This report is published on the EMA website after a 
         decision has been made either to approve or reject the 
         authorisation application. 
      The EPAR provides the public information on a medicine, 
         including how it was assessed by the EMA committees. 
                                                                                4
     European Public Assessment 
     Reports (EPAR)                                                  European Patients’ Academy 
                                                                      on Therapeutic Innovation
      Any information handled during the scientific assessment 
         that is considered confidential is removed before the 
         EPAR is published. 
      The EPAR is intended for a professional audience and 
         uses technical language. 
      It is, however, accompanied by a summary, normally two 
         or three pages long, which presents the key facts in non-
         technical language.
                                                                                5
     Clinical Trial Registries (Europe)
                                                                     European Patients’ Academy 
                                                                      on Therapeutic Innovation
      The European Clinical Trials Database (EudraCT), 
         www.clinicaltrialsregister.eu, of the European Medical 
         Agency collects information on all clinical trials of 
         medicines performed in Europe.
      From July 2014 this database also makes trial summary 
         results available to the public. 
      For trials taking place in the EU starting after 1st January 
         2015, all results must be published, both positive or 
         negative. 
                                                                                6
The words contained in this file might help you see if this file matches what you are looking for:

...Clinical study report csr european patients academy on therapeutic innovation the trial sponsor compiles a detailed after each this follows format laid down by regulatory authorities can be hundreds of pages long access to complete is usually limited and that are assessing marketing authorisation application maa public information from summarised shared with through assessment reports epars registries product journal papers conferences patient organisation websites popular news media epar when for new medicine sought via centralised procedure cp an written medicines agency ema published website decision has been made either approve or reject provides including how it was assessed committees any handled during scientific considered confidential removed before intended professional audience uses technical language however accompanied summary normally two three which presents key facts in non europe trials database eudract www clinicaltrialsregister eu medical collects all performed july ...

no reviews yet
Please Login to review.